LMAT

LeMaitre Vascular, Inc. (LMAT) 10Y Growth Potential Analysis (2026)

Invetso Score: 7.2/10 — Strong · Last Updated: 2026-08-01

Overall Score

Growth

Revenue and earnings power remain solid, supported by a 25.0% net margin and 31.9% EBIT margin.

Return on invested capital is positive at 9.8%, indicating the business is still compounding capital at a respectable rate.

No material change this month.

Profitability

Gross margin remains very high at 72.9%, with EBITDA margin at 37.1% and operating margin at 29.5%.

Return on equity is 16.4% and return on assets is 10.3%, showing efficient use of capital.

No material change this month.

Financial Health

Liquidity is exceptionally strong with a current ratio of 16.3x and quick ratio of 14.0x.

Leverage remains manageable with debt-to-equity at 0.45x and net debt to EBITDA at 1.68x.

Interest coverage is healthy at 14.9x, supporting balance-sheet resilience.

No material change this month.

Valuation

Valuation remains demanding at 7.67x EV/sales and 25.0x price/free cash flow.

The PEG ratio of 0.73 suggests growth is still partly reflected in the current price.

No material change this month.

Momentum

Operating performance remains steady, with free cash flow conversion at 89.0% of operating cash flow.

No recent news was provided to indicate a material shift in business momentum.

No material change this month.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on LeMaitre Vascular, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →